Tuesday
SESSION 5: IN HONOR OF JAMES A. DEWEESE, MD: NEW DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Wesley S. Moore, MD / Frank J. Veith, MD  
SESSION 5 SCHEDULE
1:00 PM - 1:05 PM Tips And Tricks To Make CAS Safer: Lessons Learned After More Than 3000 Procedures
  Presenter(s):Klaus D. Mathias, MD  
  View Abstract      
1:06 PM - 1:11 PM CAS Recanalization For Total ICA Occlusions: Long-Term Clinical And Image Follow-up: When Are The Procedures Worthwhile: A New Horizon
  Presenter(s):Paul H.L. Kao, MD  
  View Abstract      
1:12 PM - 1:17 PM Diagnosis And Prophylactic Treatment Of Vulnerable Plaques: Can Their Vulnerability Be Decreased By Stenting
  Presenter(s):Gregg W. Stone, MD  
  View Abstract      
1:18 PM - 1:23 PM What Is The Current Evidence For Decreasing The Incidence Of Strokes On Medical Treatment Alone: Don’t Believe The NY Times – Statins Are Safe And Should Be Used More Widely
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
  View Abstract      
1:24 PM - 1:29 PM What Constitutes Best Medical Treatment (BMRx) Currently In Asymptomatic Carotid Stenosis: What Happens To Carotid Plaques On BMRx
  Presenter(s):J. David Spence, MD  
  View Abstract      
1:30 PM - 1:35 PM Long-Term Results Of SAMMPRIS Trial In Patients With Intracranial Stenoses: What Does It Tell Us About The Feasibility And Value Of BMRx
  Presenter(s):Colin P. Derdeyn, MD / Marc I. Chimowitz, MBChB  
  View Abstract      
1:36 PM - 1:41 PM Increased Cardiovascular Mortality In Patients With Asymptomatic Carotid Stenosis Who Are Not On Statins: What Should Optimal Medical Therapy Be And Can It Decrease Plaque Size And Danger
  Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD / 
  View Abstract      
1:42 PM - 1:48 PM Panel Discussion
Moderator(s): Daniel G. Clair, MD / Jean-Pierre Becquemin, MD, FRCS  
1:48 PM - 1:53 PM Update On The ACT I Trial: A RCT Comparing CAS vs. CEA In Patients With Asymptomatic High-Grade Carotid Stenosis
  Presenter(s):Jon S. Matsumura, MD  
  View Abstract      
1:54 PM - 1:59 PM DEBATE: Medical Treatment Is Best For Patients With High-Grade Asymptomatic Carotid Stenosis (Asx CS)
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Abstract      
2:00 PM - 2:05 PM DEBATE: Carotid Endarterectomy (CEA) Is The Best Treatment For Most Patients With High-Grade Asx CS
  Presenter(s):Richard P. Cambria, MD  
  View Abstract      
2:06 PM - 2:11 PM DEBATE: Carotid Stenting (CAS) Is The Best Treatment For Most Patients With High-Grade Asx CS
  Presenter(s):William A. Gray, MD  
  View Abstract      
2:12 PM - 2:17 PM Early Results From The ACST-2 Trial: In >1500 Patients CAS And CEA Appear To Be Equivalent Treatments For Asx CS
  Presenter(s):Alison Halliday, MS, FRCS  
  View Abstract      
2:18 PM - 2:23 PM What Will CREST 2 Tell Us And When: We Must Compare CAS And CEA vs. Current Medical Treatment In Patients With Asx CS In A RCT
  Presenter(s):Thomas G. Brott, MD  
  View Abstract      
2:24 PM - 2:29 PM What Will SPACE 2 Tell Us And When: We Must Compare CAS And CEA vs. Current Medical Treatment In Patients With Asx CS In A RCT
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Abstract      
2:26 PM - 2:41 PM DEBATE: Based On The CREST RCT And Other Data, CAS Is The Best Treatment For Most Patients With Sx CS If The Right Techniques Are Used In Experienced Centers
  Presenter(s):Horst Sievert, MD  
  View Abstract      
2:30 PM - 2:35 PM DEBATE: Based On The CREST RCT And Other Data, CEA Seems To Be The Best Treatment For Symptomatic Carotid Stenosis (Sx CS) In Most Patients
  Presenter(s):Wesley S. Moore, MD  
  View Abstract      
2:42 PM - 2:50 PM Panel Discussion
2:50 PM - 3:05 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 5
previous next